1 / 12

Enrollment and Outcomes

Enrollment and Outcomes. Duckworth W, et al. N Engl J Med 2009;360:129-139. Characteristics of the Patients at Baseline and Follow-up*. Duckworth W, et al. N Engl J Med 2009;360:129-139. Changes in Median Glycated Hemoglobin Levels from Baseline through 78 Months.

brooke-levy
Download Presentation

Enrollment and Outcomes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Enrollment and Outcomes Duckworth W, et al. N Engl J Med 2009;360:129-139

  2. Characteristics of the Patients at Baseline and Follow-up* Duckworth W, et al. N Engl J Med 2009;360:129-139

  3. Changes in Median Glycated Hemoglobin Levels from Baseline through 78 Months Duckworth W, et al. N Engl J Med 2009;360:129-139

  4. Kaplan–Meier Curves for the Time until the First Occurrence of a Primary or Secondary Outcome Panel A shows the time until the first occurrence of a major cardiovascular event (the primary outcome), which was a composite of myocardial infarction, stroke, death from cardiovascular causes, congestive heart failure, surgery for vascular disease, inoperable coronary disease, and amputation for ische mic gangrene, in the standard-therapy group and the intensivetherapy group, with a hazard ratio in the intensive-therapy group of 0.88 (95% confidence interval [CI], 0.74 to 1.05). Panel B shows the time until death from a cardiovascular cause (a component of the primary outcome), with a hazard ratio of 1.32 (95% CI, 0.81 to 2.14). Panel C shows the time until death from any cause (a secondary outcome), with a hazard ratio of 1.07 (95% CI, 0.81 to 1.42). Duckworth W, et al. N Engl J Med 2009;360:129-139

  5. Hypoglycemic Episodes* Duckworth W, et al. N Engl J Med 2009;360:129-139

  6. Microvascular Outcomes* Duckworth W, et al. N Engl J Med 2009;360:129-139

  7. Time to Primary Event Duckworth W, et al. N Engl J Med 2009;360:129-139 Supplementary Appendix

  8. Time to Secondary Cardiovascular Events and Total Mortality Duckworth W, et al. N Engl J Med 2009;360:129-139 Supplementary Appendix

  9. Cause of Cardiovascular Death Duckworth W, et al. N Engl J Med 2009;360:129-139 Supplementary Appendix

  10. Cause of Death: Neoplasm (Non-cardiovascular) Duckworth W, et al. N Engl J Med 2009;360:129-139 Supplementary Appendix

  11. Other Causes of Death (Non-cardiovascular) Duckworth W, et al. N Engl J Med 2009;360:129-139 Supplementary Appendix

  12. Reporting of Confirmed SAE at least once during follow-up* Duckworth W, et al. N Engl J Med 2009;360:129-139 Supplementary Appendix

More Related